Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Okra (Abelmoschus esculentus) is a vegetable crop from the Malvaceae family with recognized nutritional and therapeutic properties, particularly regarding metabolic and inflammatory conditions [PMID:32222004, PMID:33525745].
Contexte
Okra, also known as lady's finger, is native to Africa and widely cultivated in tropical and subtropical regions [PMID:32222004, PMID:35037792]. It is valued for its nutritional content and the medicinal utility of its leaves, buds, flowers, pods, stems, and seeds [PMID:32222004, PMID:42098221].
Usages traditionnels
Traditionally used to treat various diseases and external ailments such as wounds or boils [PMID:35037792], as well as worms, dysentery, inflammation, and irritation of the stomach, intestines, and kidneys [PMID:34451728]. It is also used by populations in Africa, America, Asia, and Europe to control diabetes [PMID:35963420].
Composés actifs
Bioactive components include polyphenolic compounds (specifically oligomeric catechins and flavonol derivatives like quercetin) [PMID:32222004], flavonoids [PMID:35037792], proteins, phenolic acids, vitamins, and polysaccharides [PMID:40602582]. Its mucilage is a viscous polysaccharide composed of D-galactose, L-rhamnose, and galacturonic acid [PMID:34451728].
Mécanisme d'action
Okra polysaccharides exhibit hypoglycemic and anti-inflammatory activities [PMID:40602582]. In rat models of type 1 diabetes, okra pod extract improved blood glucose and restored splenic tissue alterations through the expression of NF-κB and CD8+ T cells [PMID:38046568].
Preuves cliniques
Preuve ADyslipidemia
A systematic review and meta-analysis of clinical studies assessed the potential impact of Abelmoschus esculentus on lipid parameters [PMID:39456704]
Preuve APrediabetes and Diabetes
A systematic review and meta-analysis of randomized controlled trials examined the effects of okra consumption on cardiometabolic risk factors [PMID:39726865]
Preuve CMetabolic Syndrome
Review indicates that while in vivo and in vitro studies show ability to overcome symptoms, there is a notable lack of clinical studies [PMID:32222004]
Sécurité et effets indésirables
The fruit and seeds are reported to be well tolerated in humans and other animals [PMID:30346086].
Synthèse des preuves
Evidence is strongest for the effects of okra on dyslipidemia and cardiometabolic risk factors in diabetes/prediabetes through systematic reviews and meta-analyses of clinical trials. Other therapeutic claims (anticancer, neuroprotective, etc.) are primarily supported by preclinical, in vitro, or review data.
Sources PubMed
1.PMID: 32222004 (2020) — Effect of Abelmoschus esculentus (okra) on metabolic syndrome: A review. · Phytotherapy research : PTR
2.PMID: 39456704 (2024) — Effect of Abelmoschus esculentus L. (Okra) on Dyslipidemia: Systematic Review and Meta-Analysis of Clinical Studies. · International journal of molecular sciences
3.PMID: 35037792 (2023) — Biological activity and development of functional foods fortified with okra (Abelmoschus esculentus). · Critical reviews in food science and nutrition
4.PMID: 33525745 (2021) — Okra (Abelmoschus Esculentus) as a Potential Dietary Medicine with Nutraceutical Importance for Sustainable Health Applications. · Molecules (Basel, Switzerland)
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
— Effects of okra (Abelmoschus esculentus (L.) Moench) on glycemic markers in animal models of diabetes: A systematic review.
· Journal of ethnopharmacology
6.PMID: 35927911 (2022) — Hydrophobically Modified Abelmoschus esculentus Polysaccharide Based Nanoparticles and Applications: A Review. · Current drug discovery technologies
7.PMID: 35244638 (2022) — Effects of okra (Abelmoschus esculentus L) on inflammatory mediators: a systematic review of preclinical studies. · Food & function
8.PMID: 34451728 (2021) — Okra (Abelmoschus esculentus L.) as a Potential Functional Food Source of Mucilage and Bioactive Compounds with Technological Applications and Health Benefits. · Plants (Basel, Switzerland)
9.PMID: 42098221 (2026) — Utilization of okra (Abelmoschus esculentus L.) and its byproducts for developing novel nutrient-rich food products. · Scientific reports
10.PMID: 40602582 (2025) — Recent progress in the polysaccharides from okra (Abelmoschus esculentus L.): Preparation methods, structural characterization, pharmacological properties, and applications. · International journal of biological macromolecules
11.PMID: 30346086 (2019) — Phytochemical information and pharmacological activities of Okra (Abelmoschus esculentus): A literature-based review. · Phytotherapy research : PTR
12.PMID: 38046568 (2023) — Okra [Abelmoschus esculentus (L.) Moench] improved blood glucose and restored histopathological alterations in splenic tissues in a rat model with streptozotocin-induced type 1 diabetes through CD8+ T cells and NF-kβ expression. · Frontiers in veterinary science
13.PMID: 39726865 (2024) — The cardiometabolic benefits of okra-based treatment in prediabetes and diabetes: a systematic review and meta-analysis of randomized controlled trials. · Frontiers in nutrition